The evaluation of P16 in chronic myeloid leukemia patients

Journal Title: Khoon - Year 2018, Vol 15, Issue 3

Abstract

The evaluation of P16 in chronic myeloid leukemia patients Barazandeh-Rokh M.1, Nasoohi N.1, Molaei M.2, Fallah P.2 1Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, Iran 2Allied-Health Faculty, Alborz University of Medical Sciences, Karaj, Iran Abstract Background and Objectives Chronic Myeloid Leukemia (CML) is a clonal disorder of the hematopoietic stem cell caused by the BCR-ABL receptor tyrosinkinase. The tumour suppressor gene of P16 plays the key role in the cell cycle control. The inactivation of this gene is associated with tumorgenesis, pathogenesis and progression of leukemia. The aim of this study was to evaluate the expression of P16 gene in patients with chronic myeloid leukemia for the identification of the gene expression changes so that the role of the gene in diagnosis and treatment of the disease could be determined. Materials and Methods In this descriptive study, the expression of P16 gene in 40 CML patients in chronic phase and 8 healthy subjects as the control all in Payvand Medical Laboratory was examined by Real Time PCR technique. Results were analyzed using the Relative Expression Software Tool (REST2009). Results P16 gene expression was significantly down-regulated in 32 patients (p ≤ 0.05), and up-regulated in 8 patients (p ≤ 0.05) compared to the control group. Conclusions In conclusion, downregulation or upregulation of P16 may be of importance in the biology of CML.Other studies are also required to elucidate the exact function of this tumor suppressor in cancer. Key words: Myeloid Leukemia، Chronic, PCR, Hematopoietic Stem Cells Received: 1 Sep 2017 Accepted: 20 May 2018 Correspondence: Fallah P., PhD of Hematology & Blood Banking. Allied-Health Faculty, Alborz University of Medical Sciences. Postal Code: 3147734568, Karaj, Iran. Tel: (+9826) 34349800; Fax: (+9826) 34349802 E-mail: parvizfallah@gmail.com

Authors and Affiliations

M. Barazandeh-Rokh, N. Nasoohi, P. Fallah

Keywords

Related Articles

ارزيابي بتا‌ ـ‌2 ميكروگلوبولين (2MG) در سرم بيماران مبتلا به منوكلونال و پلي كلونال گاماپاتي

چكيده سابقه و هدف بتا-2 ميكروگلوبولين ، پروتئيني است با‌ وزن مولكولي 11800 دالتون كه توسط سلول‌هاي هسته‌دار ساخته مي‌شود. اين پروتئين اولين باردر ادرار بيماران مبتلا به نارسايي كليه تخليص شده است . افزايش سطح سرمي ب...

The impact of neuropeptide Y on expansion of cord blood hematopoietic stem cells

Background and Objectives The low number of hematopoietic stem cells (HSCs) in each unit of UCB is a limitation for clinical application of this source of HSCs. Ex vivo expansion of HSCs to obtain a sufficient number for...

Evaluation of demographic characteristics and hepatitis B,C and HIV prevalence among blood donors in Jahrom

Evaluation of demographic characteristics and hepatitis B,C and HIV prevalence among blood donors in Jahrom Emamghorashi F.2 (MD ), Fathi G.H.2 (MD ), Mohtashami A.1,3(MD ) 1Iranian Blood Transfusion Organizati...

HOTAIR expression in newly diagnosed Acute Lymphoblastic Leukemia pateints

HOTAIR expression in newly diagnosed Acute Lymphoblastic Leukemia pateints Fallah P.1, Molaie M.2, Ehsan Heidari A.3, Soleimani M.4, Jahedi Zargar M.1, Arefian E.5, Madani T.6, Asadi M.3, Poopak B.7 1Allied-Health F...

بررسي تغييرات طول تلومر در فازهاي مزمن و بلاستيك لوسمي مزمن ميلوژن

بررسي تغييرات طول تلومر در فازهاي مزمن و بلاستيك لوسمي مزمن ميلوژن ناديا باقري1، دكتر يوسف مرتضوي2، دكتر سيد حميداله غفاري3، دكتر كامران علي مقدم4، دكتر علي‌اكبر پورفتح‌اله5، نيلوفر شايان6، دكتر اردشير قوام‌زاده7 چ...

Download PDF file
  • EP ID EP407435
  • DOI -
  • Views 75
  • Downloads 0

How To Cite

M. Barazandeh-Rokh, N. Nasoohi, P. Fallah (2018). The evaluation of P16 in chronic myeloid leukemia patients. Khoon, 15(3), 226-234. https://europub.co.uk/articles/-A-407435